| Spring-Summer
2004• Volume XIII, Number 2-3
Cancer Charities Win the Humane Charity Seal of Approval
By Kristine Kieswer
 PCRM
thanks actor Noah Wyle, also known as Dr. John Carter of NBC’s
long-running series ER, for his support of the Humane Charity Seal
of Approval program. PCRM recently ran ads featuring Noah in theater
magazines across the United States and will soon launch a print
public service ad campaign targeting nearly 7,000 outlets.
Two cancer charities—the Avon Foundation and the Cancer Treatment
Resource Foundation—join the more than 200 charitable organizations
that have been awarded the Humane Charity Seal of Approval. Since
its creation in 2000, the Humane Seal has been awarded to charities
committed to caring for people in a unique way. With concerns ranging
from physical and mental disabilities to birth defects, trauma,
and childrens’ health issues, these organizations are stellar
examples of the progress that can be made with effective medical
services and research methods that exclude animal experimentation.
The Avon Breast Cancer Crusade
The Avon Foundation meets the needs of women facing breast cancer
by funding research, clinical care, support, and education, raising
more than $250,000,000 worldwide from 1993 to 2003. Along the way,
it ensures that no breast cancer patients are left behind. With
special emphasis on low-income, elderly, and minority women, the
foundation provides vital women’s services in 50 countries.
“We were delighted to have been awarded the Humane Seal,”
said Mary Quinn, senior manager, Avon Foundation. For more information
about donating, please visit www.avoncrusade.com. To learn about
participating in an Avon Walk for Breast Cancer, please visit www.avonwalk.org.
The Cancer Treatment Resource Foundation
Since its beginning in 1992, the Cancer Treatment Resource Foundation
(CTRF) has funded over 50 clinical trials totaling over $15 million.
Extensive corporate underwriting, particularly from Cancer Treatment
Centers of America, allows for 99 cents of every dollar donated
to be applied directly to research. CTRF is currently funding innovative
research programs across the globe, including a lung cancer vaccine
study at the University of Kentucky, an investigation of a new treatment
for non-Hodgkin’s lymphoma, the introduction of interleukin-2
as a prostate cancer therapy at Malpighi Hospital in Bologna, Italy,
and a study of antioxidants and cancer risk factors at the Faculty
of Chemistry in Montevideo, Uruguay.
“It is important for CTRF to have the Humane Charity Seal
of Approval,” says CTRF President Fern Ingber. “The
CTRF is recognized as a worldwide leader and catalyst for the development
of responsive, patient-centered cancer treatment options while aggressively
working towards a cure. The fact that we conduct clinical trials
without engaging in animal experimentation only makes our efforts
more relevant and groundbreaking.”
To learn more about the foundation, please visit www.ctrf.org.
A complete list of humane charities can be found at www.HumaneSeal.org.
Media
Center | Health | Research
| About PCRM | Catalog
| Join Us | Search
| Site Index | Home
The site does
not provide medical or legal advice. This Web site is for information purposes
only.
Full Disclaimer | Privacy Policy
|
